The ACCP Pulmonary PRN mission is to improve the health of patients affected by pulmonary diseases by fostering practice innovation, supporting outcomes and translational research, and providing high-quality education to patients and practitioners. The Pulmonary PRN vision is to be the society-based organization for advancing pulmonary pharmacy practice, research, and education through collaboration, innovation, and leadership in an effort to optimize patient quality and quantity of life. The Pulmonary PRN interest areas include, but are not limited to: asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, interstitial lung diseases (ILD), collagen vascular lung diseases, cystic fibrosis, acute respiratory distress syndrome (ARDS), pulmonary hypertension, lung transplantation, lung cancer, tobacco dependence and infections of the lung. The major focus of the Pulmonary PRN is to provide a forum for like-minded practitioners to collaborate in patient care, education, and scholarly activities germane to our interests. All activities that the Pulmonary PRN engages in will be focused on achieving this goal. The Pulmonary PRN fosters multicenter prospective and retrospective research projects to advance the field.